For example, when GPX3-/- mice are crossed with the transgenic adenocarcinoma of the mouse prostate (TRAMP) mice, loss of GPx3 increases the incidence of prostate cancer in this model [102]. This evidence concerns the gene GPX3 and adenocarcinoma.